STOCK TITAN

Vicarious Surgical Inc - RBOT STOCK NEWS

Welcome to our dedicated page for Vicarious Surgical news (Ticker: RBOT), a resource for investors and traders seeking the latest updates and insights on Vicarious Surgical stock.

Vicarious Surgical Inc (RBOT) combines advanced robotics with virtual reality to transform minimally invasive surgery. This news hub provides investors and healthcare professionals with essential updates about the company's technological advancements and market position.

Access real-time information about surgical robotics innovations, regulatory milestones, and strategic partnerships. Our curated collection includes earnings reports, product development announcements, and clinical trial updates directly impacting the future of abdominal surgery techniques.

Key focus areas include 3D visualization systems, single-port surgical interfaces, and integration with existing hospital workflows. Stay informed about developments in robotic-assisted procedures that enhance surgical precision while reducing patient recovery times.

Bookmark this page for verified updates about RBOT's progress in medical robotics. Regularly updated content ensures you maintain current awareness of technological breakthroughs and industry partnerships shaping modern surgical practices.

Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) to present at Piper Sandler 35th Annual Healthcare Conference, offering a live and archived webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.73%
Tags
conferences
-
Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announces Q3 2023 financial results, revealing operating expenses of $21.4 million, a net loss of $15.7 million, and $110 million in cash. The company also revised its development schedule for the Version 1.0 System, now expected to be completed in Fall 2024 with a De Novo submission around early to mid-2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-42.71%
Tags
-
Rhea-AI Summary
Vicarious Surgical to report Q3 2023 financial results on November 13, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
conferences earnings
Rhea-AI Summary
Vicarious Surgical received a notice from NYSE for non-compliance with minimum share price requirement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.91%
Tags
none
-
Rhea-AI Summary
Vicarious Surgical signs strategic development agreement with Intermountain Health, gaining access to their network and collaborating with experienced robotic surgeons. Partnership expected to provide patients with expanded minimally invasive treatment options and surgeons enhanced tools. Positive for stock price.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.65%
Tags
partnership
-
Rhea-AI Summary
Vicarious Surgical to present at Gilmartin Group Emerging Growth Company Showcase
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.72%
Tags
conferences acquisition
Rhea-AI Summary
Vicarious Surgical Inc. will participate in the Canaccord Genuity 43rd Annual Growth Conference on August 9 at 2:30 p.m. ET. The company aims to improve patient outcomes and surgical procedure efficiency through robotics technology. A live webcast of the presentation will be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
conferences
-
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) announced the pricing of its underwritten public offering of 45,000,000 shares of its Class A common stock at $1.00 per share, with an option to purchase up to an additional 6,750,000 shares. The Company expects to receive total gross proceeds of approximately $45.0 million from the offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
-
Rhea-AI Summary
Vicarious Surgical Inc. (RBOT) has announced a public offering of $45.0 million of its Class A common stock, with an option for underwriters to purchase up to $6.75 million of additional shares. The company intends to use the proceeds for ongoing operations and the development of its single-port surgical robot, the Vicarious Surgical System.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-41.52%
Tags
Rhea-AI Summary
Vicarious Surgical Inc. (NYSE: RBOT, RBOT WS) announces Q2 2023 financial results, FDA clarity, and hospital system agreement. The company expects to complete the first ventral hernia procedure in a patient mid-2024. Operating expenses increased by 12% compared to the prior year. The company had $82.8 million in cash, cash equivalents, and short-term investments as of June 30, 2023, representing a quarterly cash burn of $14.9 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
Vicarious Surgical Inc

NYSE:RBOT

RBOT Rankings

RBOT Stock Data

31.97M
3.89M
26.35%
34.1%
1.88%
Medical Devices
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States
WALTHAM